Cargando…
Progress in the clinical detection of heterogeneity in breast cancer
Breast cancer is currently the most common form of cancer and the second‐leading cause of death from cancer in women. Though considerable progress has been made in the treatment of breast cancer, the heterogeneity of tumors (both inter‐ and intratumor) remains a considerable diagnostic and prognosti...
Autores principales: | Song, Jun‐Long, Chen, Chuang, Yuan, Jing‐Ping, Sun, Sheng‐Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224851/ https://www.ncbi.nlm.nih.gov/pubmed/27774765 http://dx.doi.org/10.1002/cam4.943 |
Ejemplares similares
-
Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients
por: Bai, Wenqi, et al.
Publicado: (2019) -
Heterogeneity derived from (18)F‐FDG PET/CT predicts immunotherapy outcome for metastatic triple‐negative breast cancer patients
por: Xie, Yizhao, et al.
Publicado: (2022) -
Single-cell RNA-sequencing reveals distinct patterns of cell state heterogeneity in mouse models of breast cancer
por: Yeo, Syn Kok, et al.
Publicado: (2020) -
Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression
por: Wang, Ying‐Yi, et al.
Publicado: (2020) -
Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis
por: Zhao, Cui-Cui, et al.
Publicado: (2021)